{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:10:11Z","timestamp":1791382211197,"version":"4.3.3"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/mao.0b013e31823e287f","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T09:25:03Z","timestamp":1325841903000},"page":"244-257","source":"Crossref","is-referenced-by-count":20,"title":["Treatment of Vestibular Schwannoma Cells With ErbB Inhibitors"],"prefix":"10.1097","volume":"33","author":[{"given":"Matthew L.","family":"Bush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah S.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Oblinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sholpan","family":"Davletova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Sheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Bradley","family":"Welling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210212","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"},{"key":"R2-21-20210212","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.","volume":"72","author":"Trofatter","year":"1993","journal-title":"Cell"},{"key":"R3-21-20210212","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MOO.0b013e3282b97310","article-title":"Molecular studies of vestibular schwannomas: a review.","volume":"15","author":"Welling","year":"2007","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"R5-21-20210212","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/00016480510030246","article-title":"Sudden sensorineural hearing loss as a revealing symptom of vestibular schwannoma.","volume":"125","author":"Sauvaget","year":"2005","journal-title":"Acta Otolaryngol"},{"key":"R6-21-20210212","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/000348940311200501","article-title":"Acoustic neuroma in patients with completely resolved sudden hearing loss.","volume":"112","author":"Nageris","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R7-21-20210212","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3171\/2009.3.JNS081053","article-title":"Effect of tumor removal on tinnitus in patients with vestibular schwannoma.","volume":"112","author":"Kameda","year":"2010","journal-title":"J Neurosurg"},{"key":"R8-21-20210212","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-4-16","article-title":"Neurofibromatosis type 2 (NF2): a clinical and molecular review.","volume":"4","author":"Evans","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"R9-21-20210212","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0896-6273(95)90147-7","article-title":"Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors.","volume":"15","author":"Dong","year":"1995","journal-title":"Neuron"},{"key":"R10-21-20210212","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.1095862","article-title":"Axonal neuregulin-1 regulates myelin sheath thickness.","volume":"304","author":"Michailov","year":"2004","journal-title":"Science"},{"key":"R11-21-20210212","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1523\/JNEUROSCI.20-12-04635.2000","article-title":"Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI3-kinase activity.","volume":"20","author":"Maurel","year":"2000","journal-title":"J Neurosci"},{"key":"R12-21-20210212","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1523\/JNEUROSCI.15-02-01329.1995","article-title":"The influence of heregulins on human Schwann cell proliferation.","volume":"15","author":"Levi","year":"1995","journal-title":"J Neurosci"},{"key":"R13-21-20210212","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0896-6273(00)80324-4","article-title":"Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis.","volume":"18","author":"Burden","year":"1997","journal-title":"Neuron"},{"key":"R14-21-20210212","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.200703010","article-title":"Contact-dependent inhibition of EGFR signaling by Nf2Merlin.","volume":"177","author":"Curto","year":"2007","journal-title":"J Cell Biol"},{"key":"R15-21-20210212","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/onc.2008.427","article-title":"Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas.","volume":"28","author":"Lallemand","year":"2009","journal-title":"Oncogene"},{"key":"R16-21-20210212","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1073\/pnas.96.9.4995","article-title":"The ErbB-2HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors.","volume":"96","author":"Klapper","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"R17-21-20210212","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/319230a0","article-title":"Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor.","volume":"319","author":"Yamamoto","year":"1986","journal-title":"Nature"},{"key":"R18-21-20210212","first-page":"165","article-title":"The biology of erbB-2neuHER-2 and its role in cancer.","volume":"1198","author":"Hynes","year":"1994","journal-title":"Biochem Biophys Acta"},{"key":"R19-21-20210212","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.jnen.0000199575.93794.2f","article-title":"Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis.","volume":"65","author":"Stonecypher","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"R20-21-20210212","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/glia.20316","article-title":"Constitutive neuregulin-1ErbB signaling contributes to human vestibular schwannoma proliferation.","volume":"53","author":"Hansen","year":"2006","journal-title":"Glia"},{"key":"R21-21-20210212","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00129492-200403000-00013","article-title":"Expression of neuregulin and activation of ErbB receptors in vestibular schwannomas: possible autocrine loop stimulation.","volume":"25","author":"Hansen","year":"2004","journal-title":"Otol Neurotol"},{"key":"R22-21-20210212","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/mao.0b013e31815dbb11","article-title":"Lipid raft localization of ErbB2 in vestibular schwannoma and Schwann cells.","volume":"29","author":"Brown","year":"2008","journal-title":"Otol Neurotol"},{"key":"R23-21-20210212","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/mao.0b013e31815d4429","article-title":"ErbB and Nrg: potential molecular targets for vestibular schwannoma pharmacotherapy.","volume":"29","author":"Doherty","year":"2008","journal-title":"Otol Neurotol"},{"key":"R24-21-20210212","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1158\/1078-0432.CCR-08-3011","article-title":"Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2.","volume":"15","author":"Evans","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R25-21-20210212","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2165\/00003495-200767140-00006","article-title":"EGFR, HER2 and VEGF pathways: validated targets for cancer treatment.","volume":"67","author":"Press","year":"2007","journal-title":"Drugs"},{"key":"R26-21-20210212","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1634\/theoncologist.7-suppl_4-2","article-title":"Why the epidermal growth factor receptor The rationale for cancer therapy.","volume":"7","author":"Baselga","year":"2002","journal-title":"Oncologist"},{"key":"R27-21-20210212","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.clinthera.2008.08.008","article-title":"Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.","volume":"30","author":"Medina","year":"2008","journal-title":"Clin Ther"},{"key":"R28-21-20210212","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signaling network.","volume":"2","author":"Yarden","year":"2001","journal-title":"Nature Rev Mol Cell Biol"},{"key":"R29-21-20210212","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1038\/sj.onc.1210477","article-title":"The oncogene HER2: its signalling and transforming functions and its role in human cancer pathogenesis.","volume":"26","author":"Moasser","year":"2007","journal-title":"Oncogene"},{"key":"R30-21-20210212","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen activated protein kinase cascade for the treatment of cancer.","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"R31-21-20210212","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2neu protooncogene in human breast and ovarian cancer.","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"R32-21-20210212","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0022-5347(05)00317-4","article-title":"Gene expression profiling of ERBB receptors and ligands in human transitional cell carcinoma of the bladder.","volume":"175","author":"Amsellem-Ouazana","year":"2006","journal-title":"J Urol"},{"key":"R33-21-20210212","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ijc.11273","article-title":"Prognostic value of ERBB family mRNA expression in breast carcinomas.","volume":"106","author":"Bieche","year":"2003","journal-title":"Int J Cancer"},{"key":"R34-21-20210212","first-page":"5346","article-title":"Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.","volume":"9","author":"Junttila","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R35-21-20210212","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1054\/bjoc.1999.1057","article-title":"ErbB4 protein expression in human breast cancer.","volume":"82","author":"Kew","year":"2000","journal-title":"Br J Cancer"},{"key":"R36-21-20210212","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1074\/jbc.271.9.5251","article-title":"All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired.","volume":"271","author":"Baulida","year":"1996","journal-title":"J Biol Chem"},{"key":"R37-21-20210212","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1093\/emboj\/18.12.3348","article-title":"The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.","volume":"18","author":"Waterman","year":"1999","journal-title":"EMBO J"},{"key":"R38-21-20210212","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1002\/j.1460-2075.1995.tb00101.x","article-title":"Heregulin-dependent regulation of HER2neu oncogenic signaling by heterodimerization with HER3.","volume":"14","author":"Wallasch","year":"1995","journal-title":"EMBO J"},{"key":"R39-21-20210212","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1101\/gad.14.13.1617","article-title":"Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.","volume":"14","author":"Giovannini","year":"2000","journal-title":"Genes Dev"},{"key":"R40-21-20210212","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-0270(02)00349-7","article-title":"Magnetic cell sorting for enriching Schwann cells from adult mouse peripheral nerves.","volume":"123","author":"Manent","year":"2003","journal-title":"J Neurosci Methods"},{"key":"R41-21-20210212","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/neuonc\/noq012","article-title":"ErbBHER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma.","volume":"12","author":"Ammoun","year":"2010","journal-title":"Neuro Oncol"},{"key":"R42-21-20210212","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1158\/0008-5472.CAN-07-5849","article-title":"Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma.","volume":"68","author":"Ammoun","year":"2008","journal-title":"Cancer Res"},{"key":"R43-21-20210212","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1365-2273.2000.00422-17.x","article-title":"Fibroblast growth factor receptor expression in vestibular schwannoma.","volume":"25","author":"Nair","year":"2000","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"R44-21-20210212","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/MAO.0b013e31817f7398","article-title":"The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.","volume":"29","author":"Clark","year":"2008","journal-title":"Otol Neurotol"},{"key":"R45-21-20210212","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ncponc1157","article-title":"Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy.","volume":"5","author":"Plotkin","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"R47-21-20210212","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1073\/pnas.1016140108","article-title":"Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase.","volume":"108","author":"Garrett","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R48-21-20210212","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4161\/cbt.6.4.3849","article-title":"ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib.","volume":"6","author":"Frolov","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"R49-21-20210212","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bjc.2011.263","article-title":"Targeting ErbB3-mediated stromal-epithelial interactions in pancreatic ductal adenocarcinoma.","volume":"105","author":"Liles","year":"2011","journal-title":"Br J Cancer"},{"key":"R50-21-20210212","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature05474","article-title":"Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3.","volume":"445","author":"Sergina","year":"2007","journal-title":"Nature"},{"key":"R51-21-20210212","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/mao.0b013e31816021f7","article-title":"Phosphatidylinositol 3-kinaseAKT pathway activation in human vestibular schwannoma.","volume":"29","author":"Jacob","year":"2008","journal-title":"Otol Neurotol"},{"key":"R52-21-20210212","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/jnci\/djn216","article-title":"Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain.","volume":"100","author":"Gril","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R53-21-20210212","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.2007.12.3588","article-title":"Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.","volume":"26","author":"Lin","year":"2008","journal-title":"J Clin Oncol"},{"key":"R55-21-20210212","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2003.11.041","article-title":"Review of epidermal growth factor receptor biology.","volume":"59","author":"Herbst","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Otology & Neurotology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MAO.0b013e31823e287f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:27:32Z","timestamp":1786048052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00129492-201202000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mao.0b013e31823e287f","relation":{},"ISSN":["1531-7129"],"issn-type":[{"value":"1531-7129","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}